Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Helps Interpret Ambiguous Mammography Results

By HospiMedica International staff writers
Posted on 13 Feb 2018
A new study shows that magnetic resonance imaging (MRI) is the best choice for clarifying ambiguous mammography tests.

Researchers at the Medical University of Vienna (MedUni; Austria) and Diagnostikum Graz (Austria) conducted a retrospective study of 302 consecutive women (mean age 50 years) who underwent 3T breast MRI as an additional workup to conventional and clinical mammography findings. More...
The aim of the study was to investigate diagnostic performance and incidental lesion yield when using MRI as a problem-solving tool. All images were read by experienced, board-certified radiologists, with the reference standard being histopathology or follow-up after two years.

The researchers also developed a multiparametric protocol, which allows the examination of up to four patients per hour. The results revealed 53 true-positive, 243 true-negative, 20 false-positive, and two false-negative breast MRI findings. In 16 (5.3%) of all patients, incidental MRI lesions were detected, 37.5% of which were found to be malignant. Breast composition and the imaging findings that had led to referral in the first place had no significant influence on the diagnostic performance of breast MRI. The study was published on January 2, 2018, in PLOS One.

"MRI clearly shows whether findings are benign or malignant. Not only was MRI able to definitively characterize ambiguous findings as either benign or malignant but, on top of this, we were able to detect additional, previously undiscovered, malignant tumors,” said lead author Claudio Spick, of MedUni Vienna. “MRI scans are therefore an ideal, non-invasive and equivalent alternative to painful breast biopsies; moreover, in around five percent of cases they identify previously undetected malignant tumors.”

While breast MRI provides a very high sensitivity and negative predictive value, particularly in non-calcified breast lesions, problem-solving definitions are not well defined, and the empirical evidence about specific indications, such as architectural distortions, is sparse.

Related Links:
Medical University of Vienna
Diagnostikum Graz


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical System
Stealth AXiS
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.